State Policies Related to Substance Use in Pregnancy Wheels

Faherty, Laura J.; Kranz, Ashley M.; Russell-Fritch, Joshua; Patrick, Stephen W.; Cantor, Jonathan; Stein, Bradley D.

doi:10.7249/ig148

Cited by 7 publications

(6 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Still, it was also found that some pregnant women used them in combination. In this regard, Qato [26] stated that the consumption of alcohol cannabinoids persists during pregnancy, and this will cause several dangerous effects on the fetus, as also described by Faherty et al [27] In this regard, Young-Wolff et al [32] affirms that depression before, during, and after preg-nancy, by itself, constitutes a risk for the development, in children, of cognitive and behavioral disorders such as ADHD. Therefore, it should be taken into account-special care with antidepressants is used for its management due to the possible consequences on child development.…”

Section: Discussionmentioning

confidence: 99%

Neurodevelopmental Abnormalities in Children Associated with Maternal Use of Psychoactive Medication

et al. 2022

View full text Add to dashboard Cite

Background: Due to its negative effects on the unborn child and the mother as a consumer, pregnant women's intake of psychoactive substances has become a public health concern. Additionally, consuming these chemicals has been linked to several neurological development changes in children, including behavioral issues (such as attention deficit hyperactivity disorder and autism spectrum disorder), cognitive issues, and sensory and motor function changes. Objectives: To perform a thorough, comprehensive study of the neurodevelopmental problems in children linked to maternal drug use. Method: A search of the scientific literature on studies about neurodevelopmental abnormalities linked to maternal use of psychoactive medications during pregnancy and published in the previous ten years up to June 2022 was conducted from PubMed, Google Scholar, and Directory open access Journals. Results: The initial screening identified 380 articles. We excluded 50 unaccessible articles and 160 articles due to publication dates and study types; after that, 62 articles were also discarded because they were duplicates, and 68 were excluded because the information was irrelevant or systemic reviews, so we finally obtained 40 articles for full-text reading distributed as follows: 18 from PubMed, 12 from Directory Open Access Journal, and 10 from Google scholar

show abstract

Section: Discussionmentioning

confidence: 99%

Neurodevelopmental Abnormalities in Children Associated with Maternal Use of Psychoactive Medication

et al. 2022

View full text Add to dashboard Cite

show abstract

“…Moreover, few OTPs likely have sustained tailored programs for pregnant individuals. 44 Therefore, more OTPs in a county might not translate to more practitioners having this level of comfort in prescribing to this sub-population. Yet, we know from the parent study 13 that in contrast to buprenorphine-waivered prescribers, we do not have evidence to suggest that OTPs differentiate appointment access between pregnant and nonpregnant callers.…”

Section: Discussionmentioning

confidence: 99%

County-level Factors and Treatment Access Among Insured Women With Opioid Use Disorder

Leech¹,

McNeer

Stein

et al. 2023

Medical Care

View full text Add to dashboard Cite

Background: An over 40% increase in overdose deaths within the past 2 years and low levels of engagement in treatment call for a better understanding of factors that influence access to medication for opioid use disorder (OUD). Objective: To examine whether county-level characteristics influence a caller’s ability to secure an appointment with an OUD treatment practitioner, either a buprenorphine-waivered prescriber or an opioid treatment program (OTP). Research Design and Subjects: We leveraged data from a randomized field experiment comprised of simulated pregnant and nonpregnant women of reproductive age seeking treatment for OUD among 10 states in the US. We employed a mixed-effects logistic regression model with random intercepts for counties to examine the relationship between appointments received and salient county-level factors related to OUD. Measures: Our primary outcome was the caller’s ability to secure an appointment with an OUD treatment practitioner. County-level predictor variables included socioeconomic disadvantage rankings, rurality, and OUD treatment/practitioner density. Results: Our sample comprised 3956 reproductive-aged callers; 86% reached a buprenorphine-waivered prescriber and 14% an OTP. We found that 1 additional OTP per 100,000 population was associated with an increase (OR=1.36, 95% CI: 1.08 to 1.71) in the likelihood that a nonpregnant caller receives an OUD treatment appointment from any practitioner. Conclusions: When OTPs are highly concentrated within a county, women of reproductive age with OUD have an easier time securing an appointment with any practitioner. This finding may suggest greater practitioners’ comfort in prescribing when there are robust OUD specialty safety nets in the county.

show abstract

“…Following the method used by Thomas, Treffers, Berglas, Drabble, and Roberts (2018), we categorize each state's policy environment in each year as 1) supportive policies only, 2) punitive policies only, 3) both supportive and punitive policies, or 4) no policy. We updated Thomas et al (2018) by using more recent sources including Guttmacher Institute (2021) and Faherty et al (2020). Discrepancies in the information of state-level supportive and punitive policies were resolved by reviewing legal databases, peerreviewed journals, and news articles.…”

Section: Methodsmentioning

confidence: 99%

The Implementation of the Tennessee Fetal Assault Law and Its Association With Out-of-State Births Among Residents of Tennessee

Choi¹,

Agbese²,

Cohrs³

et al. 2023

Women's Health Issues

View full text Add to dashboard Cite

State Policies Related to Substance Use in Pregnancy Wheels

Cited by 7 publications

References 0 publications

Neurodevelopmental Abnormalities in Children Associated with Maternal Use of Psychoactive Medication

Neurodevelopmental Abnormalities in Children Associated with Maternal Use of Psychoactive Medication

County-level Factors and Treatment Access Among Insured Women With Opioid Use Disorder

The Implementation of the Tennessee Fetal Assault Law and Its Association With Out-of-State Births Among Residents of Tennessee

Contact Info

Product

Resources

About